Compare,PMID,Parameter,Sentece,Title,Type,URL,Units,Value,id,Drugbank_id,Name
,10823093,peripheral volume of distribution,"Although isoflurane and sevoflurane have almost the same tissue/blood partition coefficients, significant differences between substances were observed for the peripheral volume of distribution (medians and ranges: desflurane, 612 (343-1850) mlvapour kgbw-1; isoflurane, 4112 (1472-9396) mlvapour kgbw-1; sevoflurane, 1634 (762-8843) mlvapour kgbw-1) and the transport clearance from the central to the peripheral compartment (desflurane, 7.0 (4.4-11.1) mlvapour kgbw-1 min-1; isoflurane, 30.7 (15.9-38.7) mlvapour kgbw-1 min-1; sevoflurane, 13.0 (9.8-22.4) mlvapour kgbw-1 min-1).","Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. ",V2-Q64,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10823093/),[mlvapour] / [kgbw],612,381,DB01189,Desflurane
,10823093,peripheral volume of distribution,"Although isoflurane and sevoflurane have almost the same tissue/blood partition coefficients, significant differences between substances were observed for the peripheral volume of distribution (medians and ranges: desflurane, 612 (343-1850) mlvapour kgbw-1; isoflurane, 4112 (1472-9396) mlvapour kgbw-1; sevoflurane, 1634 (762-8843) mlvapour kgbw-1) and the transport clearance from the central to the peripheral compartment (desflurane, 7.0 (4.4-11.1) mlvapour kgbw-1 min-1; isoflurane, 30.7 (15.9-38.7) mlvapour kgbw-1 min-1; sevoflurane, 13.0 (9.8-22.4) mlvapour kgbw-1 min-1).","Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. ",V2-Q64,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10823093/),[mlvapour] / [kgbw],4112,382,DB01189,Desflurane
,10823093,peripheral volume of distribution,"Although isoflurane and sevoflurane have almost the same tissue/blood partition coefficients, significant differences between substances were observed for the peripheral volume of distribution (medians and ranges: desflurane, 612 (343-1850) mlvapour kgbw-1; isoflurane, 4112 (1472-9396) mlvapour kgbw-1; sevoflurane, 1634 (762-8843) mlvapour kgbw-1) and the transport clearance from the central to the peripheral compartment (desflurane, 7.0 (4.4-11.1) mlvapour kgbw-1 min-1; isoflurane, 30.7 (15.9-38.7) mlvapour kgbw-1 min-1; sevoflurane, 13.0 (9.8-22.4) mlvapour kgbw-1 min-1).","Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. ",V2-Q64,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10823093/),[mlvapour] / [kgbw],1634,383,DB01189,Desflurane
,10823093,transport clearance from,"Although isoflurane and sevoflurane have almost the same tissue/blood partition coefficients, significant differences between substances were observed for the peripheral volume of distribution (medians and ranges: desflurane, 612 (343-1850) mlvapour kgbw-1; isoflurane, 4112 (1472-9396) mlvapour kgbw-1; sevoflurane, 1634 (762-8843) mlvapour kgbw-1) and the transport clearance from the central to the peripheral compartment (desflurane, 7.0 (4.4-11.1) mlvapour kgbw-1 min-1; isoflurane, 30.7 (15.9-38.7) mlvapour kgbw-1 min-1; sevoflurane, 13.0 (9.8-22.4) mlvapour kgbw-1 min-1).","Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. ",CL12-Q30,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10823093/),[mlvapour] / [kgbw·min],7.0,384,DB01189,Desflurane
,10823093,transport clearance from,"Although isoflurane and sevoflurane have almost the same tissue/blood partition coefficients, significant differences between substances were observed for the peripheral volume of distribution (medians and ranges: desflurane, 612 (343-1850) mlvapour kgbw-1; isoflurane, 4112 (1472-9396) mlvapour kgbw-1; sevoflurane, 1634 (762-8843) mlvapour kgbw-1) and the transport clearance from the central to the peripheral compartment (desflurane, 7.0 (4.4-11.1) mlvapour kgbw-1 min-1; isoflurane, 30.7 (15.9-38.7) mlvapour kgbw-1 min-1; sevoflurane, 13.0 (9.8-22.4) mlvapour kgbw-1 min-1).","Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. ",CL12-Q30,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10823093/),[mlvapour] / [kgbw·min],30.7,385,DB01189,Desflurane
,10823093,transport clearance from,"Although isoflurane and sevoflurane have almost the same tissue/blood partition coefficients, significant differences between substances were observed for the peripheral volume of distribution (medians and ranges: desflurane, 612 (343-1850) mlvapour kgbw-1; isoflurane, 4112 (1472-9396) mlvapour kgbw-1; sevoflurane, 1634 (762-8843) mlvapour kgbw-1) and the transport clearance from the central to the peripheral compartment (desflurane, 7.0 (4.4-11.1) mlvapour kgbw-1 min-1; isoflurane, 30.7 (15.9-38.7) mlvapour kgbw-1 min-1; sevoflurane, 13.0 (9.8-22.4) mlvapour kgbw-1 min-1).","Pharmacokinetics of inhaled anaesthetics in a clinical setting: comparison of desflurane, isoflurane and sevoflurane. ",CL12-Q30,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10823093/),[mlvapour] / [kgbw·min],13.0,386,DB01189,Desflurane
,2400116,blood/gas partition coefficient,"The blood/gas partition coefficient of desflurane (0.35 +/- 0.02) was significantly smaller (P less than 0.01) than that of sevoflurane (0.45 +/- 0.02), isoflurane (0.94 +/- 0.05), and halothane (2.54 +/- 0.21).","Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2400116/),,0.35,2177,DB01189,Desflurane
,2400116,blood/gas partition coefficient,"The blood/gas partition coefficient of desflurane (0.35 +/- 0.02) was significantly smaller (P less than 0.01) than that of sevoflurane (0.45 +/- 0.02), isoflurane (0.94 +/- 0.05), and halothane (2.54 +/- 0.21).","Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2400116/),,0.45,2178,DB01189,Desflurane
,2400116,blood/gas partition coefficient,"The blood/gas partition coefficient of desflurane (0.35 +/- 0.02) was significantly smaller (P less than 0.01) than that of sevoflurane (0.45 +/- 0.02), isoflurane (0.94 +/- 0.05), and halothane (2.54 +/- 0.21).","Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2400116/),,0.94,2179,DB01189,Desflurane
,2400116,blood/gas partition coefficient,"The blood/gas partition coefficient of desflurane (0.35 +/- 0.02) was significantly smaller (P less than 0.01) than that of sevoflurane (0.45 +/- 0.02), isoflurane (0.94 +/- 0.05), and halothane (2.54 +/- 0.21).","Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2400116/),,2.54,2180,DB01189,Desflurane
,2400116,Recovery,"Recovery (normalized to that of isoflurane) of the volume of anesthetic taken up was significantly greater (P less than 0.05) for desflurane (93% +/- 7% [mean +/- SD]) than for halothane (77% +/- 6%), was not different from that of isoflurane (100%), but was less than that for sevoflurane (111% +/- 17%).","Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2400116/),%,93,2181,DB01189,Desflurane
,2400116,Recovery,"Recovery (normalized to that of isoflurane) of the volume of anesthetic taken up was significantly greater (P less than 0.05) for desflurane (93% +/- 7% [mean +/- SD]) than for halothane (77% +/- 6%), was not different from that of isoflurane (100%), but was less than that for sevoflurane (111% +/- 17%).","Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2400116/),%,77,2182,DB01189,Desflurane
,2400116,Recovery,"Recovery (normalized to that of isoflurane) of the volume of anesthetic taken up was significantly greater (P less than 0.05) for desflurane (93% +/- 7% [mean +/- SD]) than for halothane (77% +/- 6%), was not different from that of isoflurane (100%), but was less than that for sevoflurane (111% +/- 17%).","Pharmacokinetics of desflurane, sevoflurane, isoflurane, and halothane in pigs. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2400116/),%,111,2183,DB01189,Desflurane
,31303447,plasma alfaxalone,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],0.73,25405,DB01189,Desflurane
,31303447,plasma alfaxalone,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],1.42,25406,DB01189,Desflurane
,31303447,plasma alfaxalone,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],3.44,25407,DB01189,Desflurane
,31303447,plasma alfaxalone,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],6.56,25408,DB01189,Desflurane
,31303447,plasma alfaxalone,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],18.88,25409,DB01189,Desflurane
,31303447,plasma alfaxalone,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],49.47,25410,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],0.73,25411,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],1.42,25412,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],3.44,25413,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],6.56,25414,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],18.88,25415,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),[mg] / [l],49.47,25416,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),mg,1,25417,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),mg,3.8,25418,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),mg,7.6,25419,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),mg,15.2,25420,DB01189,Desflurane
,31303447,concentrations,"Mean ± standard deviation plasma alfaxalone concentrations were 0.73 ± 0.32, 1.42 ± 0.41, 3.44 ± 0.40, 6.56 ± 0.43, 18.88 ± 6.81 and 49.47 ± 5.50 mg L-1 for the 1, 1.9, 3.8, 7.6, 15.2, and 30.4 mg L-1 target concentrations, respectively.","Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),mg,30.4,25421,DB01189,Desflurane
,31303447,PaCO2,PaCO2 increased with increasing target plasma alfaxalone concentrations and was 69.4 ± 14.2 mmHg (9.3 ± 1.9 kPa) at the 30.4 mg L-1 target.,"Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),mmhg,69.4,25422,DB01189,Desflurane
,31303447,PaCO2,PaCO2 increased with increasing target plasma alfaxalone concentrations and was 69.4 ± 14.2 mmHg (9.3 ± 1.9 kPa) at the 30.4 mg L-1 target.,"Hemodynamic effects of subclinical, clinical and supraclinical plasma alfaxalone concentrations in cats. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/31303447/),kpa,9.3,25423,DB01189,Desflurane
,2001020,MAC,"The MAC of desflurane in O2 was 7.25 +/- 0.0 (mean +/- SD) in the 18-30-yr age group, and 6.0 +/- 0.29 in the 31-65-yr group; the addition of 60% N2O reduced the MAC to 4.0 +/- 0.29 and 2.83 +/- 0.58, respectively.",Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001020/),,7.25,26707,DB01189,Desflurane
,2001020,MAC,"The MAC of desflurane in O2 was 7.25 +/- 0.0 (mean +/- SD) in the 18-30-yr age group, and 6.0 +/- 0.29 in the 31-65-yr group; the addition of 60% N2O reduced the MAC to 4.0 +/- 0.29 and 2.83 +/- 0.58, respectively.",Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001020/),,6.0,26708,DB01189,Desflurane
,2001020,MAC,"The MAC of desflurane in O2 was 7.25 +/- 0.0 (mean +/- SD) in the 18-30-yr age group, and 6.0 +/- 0.29 in the 31-65-yr group; the addition of 60% N2O reduced the MAC to 4.0 +/- 0.29 and 2.83 +/- 0.58, respectively.",Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001020/),,4.0,26709,DB01189,Desflurane
,2001020,MAC,"The MAC of desflurane in O2 was 7.25 +/- 0.0 (mean +/- SD) in the 18-30-yr age group, and 6.0 +/- 0.29 in the 31-65-yr group; the addition of 60% N2O reduced the MAC to 4.0 +/- 0.29 and 2.83 +/- 0.58, respectively.",Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001020/),,2.83,26710,DB01189,Desflurane
,2001020,time,The median time from discontinuation of desflurane to an appropriate response to commands was 5.25 min.,Clinical characteristics of desflurane in surgical patients: minimum alveolar concentration. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001020/),min,5.25,26711,DB01189,Desflurane
,26440992,wash-in time to P50,"The uptake and elimination of desflurane in arterial blood was delayed by nebulization of MCh, as determined by Micropore Membrane Inlet Mass Spectrometry (wash-in time to P50, healthy vs. inhalation: 0.5 min vs. 1.1 min, to P90: 4.0 min vs. 14.8 min).",Bronchoconstriction induced by inhaled methacholine delays desflurane uptake and elimination in a piglet model. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26440992/),min,0.5,65752,DB01189,Desflurane
,26440992,wash-in time to P50,"The uptake and elimination of desflurane in arterial blood was delayed by nebulization of MCh, as determined by Micropore Membrane Inlet Mass Spectrometry (wash-in time to P50, healthy vs. inhalation: 0.5 min vs. 1.1 min, to P90: 4.0 min vs. 14.8 min).",Bronchoconstriction induced by inhaled methacholine delays desflurane uptake and elimination in a piglet model. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26440992/),min,1.1,65753,DB01189,Desflurane
,26440992,P90,"The uptake and elimination of desflurane in arterial blood was delayed by nebulization of MCh, as determined by Micropore Membrane Inlet Mass Spectrometry (wash-in time to P50, healthy vs. inhalation: 0.5 min vs. 1.1 min, to P90: 4.0 min vs. 14.8 min).",Bronchoconstriction induced by inhaled methacholine delays desflurane uptake and elimination in a piglet model. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26440992/),min,4.0,65754,DB01189,Desflurane
,26440992,P90,"The uptake and elimination of desflurane in arterial blood was delayed by nebulization of MCh, as determined by Micropore Membrane Inlet Mass Spectrometry (wash-in time to P50, healthy vs. inhalation: 0.5 min vs. 1.1 min, to P90: 4.0 min vs. 14.8 min).",Bronchoconstriction induced by inhaled methacholine delays desflurane uptake and elimination in a piglet model. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26440992/),min,14.8,65755,DB01189,Desflurane
,17529920,effect site concentration,Obese patients were intubated using a flexible fiberoptic bronchoscopic technique facilitated by a target controlled effect site concentration of remifentanil set at 2.5 ng/mL.,Effect of morbid obesity on kinetic of desflurane: wash-in wash-out curves and recovery times. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/17529920/),[ng] / [ml],2.5,69936,DB01189,Desflurane
,2001028,FA/FI,"FA/FI values at 30 min of administration were: (mean +/- SD) nitrous oxide 0.99 +/- 0.01, desflurane 0.90 +/- 0.01, isoflurane 0.73 +/- 0.03, and halothane 0.58 +/- 0.04.","Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),,0.99,113473,DB01189,Desflurane
,2001028,FA/FI,"FA/FI values at 30 min of administration were: (mean +/- SD) nitrous oxide 0.99 +/- 0.01, desflurane 0.90 +/- 0.01, isoflurane 0.73 +/- 0.03, and halothane 0.58 +/- 0.04.","Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),,0.90,113474,DB01189,Desflurane
,2001028,FA/FI,"FA/FI values at 30 min of administration were: (mean +/- SD) nitrous oxide 0.99 +/- 0.01, desflurane 0.90 +/- 0.01, isoflurane 0.73 +/- 0.03, and halothane 0.58 +/- 0.04.","Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),,0.73,113475,DB01189,Desflurane
,2001028,FA/FI,"FA/FI values at 30 min of administration were: (mean +/- SD) nitrous oxide 0.99 +/- 0.01, desflurane 0.90 +/- 0.01, isoflurane 0.73 +/- 0.03, and halothane 0.58 +/- 0.04.","Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),,0.58,113476,DB01189,Desflurane
,2001028,FA/FA0,"FA/FA0 values after 5 min of elimination were: desflurane 0.14 +/- 0.02, isoflurane 0.22 +/- 0.02, and halothane 0.25 +/- 0.02.","Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),,0.14,113477,DB01189,Desflurane
,2001028,FA/FA0,"FA/FA0 values after 5 min of elimination were: desflurane 0.14 +/- 0.02, isoflurane 0.22 +/- 0.02, and halothane 0.25 +/- 0.02.","Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),,0.22,113478,DB01189,Desflurane
,2001028,FA/FA0,"FA/FA0 values after 5 min of elimination were: desflurane 0.14 +/- 0.02, isoflurane 0.22 +/- 0.02, and halothane 0.25 +/- 0.02.","Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),,0.25,113479,DB01189,Desflurane
,2001028,Recovery,Recovery (volume of anesthetic recovered during elimination per volume taken up) of desflurane (105 +/- 25%) equalled recovery of isoflurane (102 +/- 13%) and exceeded recovery of halothane (64 +/- 9%).,"Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),%,105,113480,DB01189,Desflurane
,2001028,Recovery,Recovery (volume of anesthetic recovered during elimination per volume taken up) of desflurane (105 +/- 25%) equalled recovery of isoflurane (102 +/- 13%) and exceeded recovery of halothane (64 +/- 9%).,"Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),%,102,113481,DB01189,Desflurane
,2001028,Recovery,Recovery (volume of anesthetic recovered during elimination per volume taken up) of desflurane (105 +/- 25%) equalled recovery of isoflurane (102 +/- 13%) and exceeded recovery of halothane (64 +/- 9%).,"Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),%,64,113482,DB01189,Desflurane
,2001028,volume of,Recovery (volume of anesthetic recovered during elimination per volume taken up) of desflurane (105 +/- 25%) equalled recovery of isoflurane (102 +/- 13%) and exceeded recovery of halothane (64 +/- 9%).,"Kinetics of desflurane, isoflurane, and halothane in humans. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/2001028/),%,105,113483,DB01189,Desflurane
,10526823,end-tidal concentration (FA,"Mean end-tidal concentration (FA = FA0) at the end of anesthesia was 6.34 +/- 1.15% after desflurane, 1.85 +/- 0.42% after sevoflurane, and 1.10 +/- 0.24% after isoflurane.","Recovery and pharmacokinetic parameters of desflurane, sevoflurane, and isoflurane in patients undergoing urologic procedures. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10526823/),%,6.34,133161,DB01189,Desflurane
,10526823,end-tidal concentration (FA,"Mean end-tidal concentration (FA = FA0) at the end of anesthesia was 6.34 +/- 1.15% after desflurane, 1.85 +/- 0.42% after sevoflurane, and 1.10 +/- 0.24% after isoflurane.","Recovery and pharmacokinetic parameters of desflurane, sevoflurane, and isoflurane in patients undergoing urologic procedures. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10526823/),%,1.85,133162,DB01189,Desflurane
,10526823,end-tidal concentration (FA,"Mean end-tidal concentration (FA = FA0) at the end of anesthesia was 6.34 +/- 1.15% after desflurane, 1.85 +/- 0.42% after sevoflurane, and 1.10 +/- 0.24% after isoflurane.","Recovery and pharmacokinetic parameters of desflurane, sevoflurane, and isoflurane in patients undergoing urologic procedures. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10526823/),%,1.10,133163,DB01189,Desflurane
,10526823,terminal half-life (t1/2),"As for the terminal half-life (t1/2), there were no differences among the groups (8.16 +/- 3.15 min after desflurane, 9.47 +/- 4.46 min after sevoflurane, and 10.0 +/- 5.57 min after isoflurane).","Recovery and pharmacokinetic parameters of desflurane, sevoflurane, and isoflurane in patients undergoing urologic procedures. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/10526823/),min,8.16,133164,DB01189,Desflurane
,10526823,terminal half-life (t1/2),"As for the terminal half-life (t1/2), there were no differences among the groups (8.16 +/- 3.15 min after desflurane, 9.47 +/- 4.46 min after sevoflurane, and 10.0 +/- 5.57 min after isoflurane).","Recovery and pharmacokinetic parameters of desflurane, sevoflurane, and isoflurane in patients undergoing urologic procedures. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/10526823/),min,9.47,133165,DB01189,Desflurane
,10526823,terminal half-life (t1/2),"As for the terminal half-life (t1/2), there were no differences among the groups (8.16 +/- 3.15 min after desflurane, 9.47 +/- 4.46 min after sevoflurane, and 10.0 +/- 5.57 min after isoflurane).","Recovery and pharmacokinetic parameters of desflurane, sevoflurane, and isoflurane in patients undergoing urologic procedures. ","t1/2,β-Q60",[Article Link](https://pubmed.ncbi.nlm.nih.gov/10526823/),min,10.0,133166,DB01189,Desflurane
,10526823,time until a command was followed,"The time until a command was followed for the first time was the same in all three groups (13.0 +/- 4.7 min after desflurane, 13.4 +/- 4.4 min after sevoflurane, and 13.6 +/- 3.4 min after isoflurane).","Recovery and pharmacokinetic parameters of desflurane, sevoflurane, and isoflurane in patients undergoing urologic procedures. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10526823/),min,13.0,133167,DB01189,Desflurane
,10526823,time until a command was followed,"The time until a command was followed for the first time was the same in all three groups (13.0 +/- 4.7 min after desflurane, 13.4 +/- 4.4 min after sevoflurane, and 13.6 +/- 3.4 min after isoflurane).","Recovery and pharmacokinetic parameters of desflurane, sevoflurane, and isoflurane in patients undergoing urologic procedures. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10526823/),min,13.4,133168,DB01189,Desflurane
,10526823,time until a command was followed,"The time until a command was followed for the first time was the same in all three groups (13.0 +/- 4.7 min after desflurane, 13.4 +/- 4.4 min after sevoflurane, and 13.6 +/- 3.4 min after isoflurane).","Recovery and pharmacokinetic parameters of desflurane, sevoflurane, and isoflurane in patients undergoing urologic procedures. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/10526823/),min,13.6,133169,DB01189,Desflurane
,11312475,CPB time,"CPB time was 116 +/- 10 minutes, and ischemic time was 81 +/- 6 minutes.",Desflurane pharmacokinetics during cardiopulmonary bypass. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11312475/),min,116,154299,DB01189,Desflurane
,11312475,ischemic time,"CPB time was 116 +/- 10 minutes, and ischemic time was 81 +/- 6 minutes.",Desflurane pharmacokinetics during cardiopulmonary bypass. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11312475/),min,81,154300,DB01189,Desflurane
,11312475,pump flow,"Mean pump flow was 4.49 +/- 0.03 L/min, and mean arterial pressure was 70.1 +/- 1 mmHg during the study period.",Desflurane pharmacokinetics during cardiopulmonary bypass. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11312475/),[l] / [min],4.49,154301,DB01189,Desflurane
,11038831,fraction (Fd),"After induction of anesthesia and endotracheal intubation, desired fraction (Fd) of desflurane(6%), sevoflurane(2%), isoflurane (1.15%) and enflurane(1.7%) in oxygen and nitrous oxide(1:2) were inhaled in D, S, I and E groups, respectively.","[The pharmacokinetic study of desflurane, sevoflurane, isoflurane and enflurane in general anesthesia]. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11038831/),%,6,171264,DB01189,Desflurane
,11038831,fraction (Fd),"After induction of anesthesia and endotracheal intubation, desired fraction (Fd) of desflurane(6%), sevoflurane(2%), isoflurane (1.15%) and enflurane(1.7%) in oxygen and nitrous oxide(1:2) were inhaled in D, S, I and E groups, respectively.","[The pharmacokinetic study of desflurane, sevoflurane, isoflurane and enflurane in general anesthesia]. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11038831/),%,2,171265,DB01189,Desflurane
,11038831,fraction (Fd),"After induction of anesthesia and endotracheal intubation, desired fraction (Fd) of desflurane(6%), sevoflurane(2%), isoflurane (1.15%) and enflurane(1.7%) in oxygen and nitrous oxide(1:2) were inhaled in D, S, I and E groups, respectively.","[The pharmacokinetic study of desflurane, sevoflurane, isoflurane and enflurane in general anesthesia]. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11038831/),%,1.15,171266,DB01189,Desflurane
,11038831,fraction (Fd),"After induction of anesthesia and endotracheal intubation, desired fraction (Fd) of desflurane(6%), sevoflurane(2%), isoflurane (1.15%) and enflurane(1.7%) in oxygen and nitrous oxide(1:2) were inhaled in D, S, I and E groups, respectively.","[The pharmacokinetic study of desflurane, sevoflurane, isoflurane and enflurane in general anesthesia]. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11038831/),%,1.7,171267,DB01189,Desflurane
,11038831,fractional end tidal alveolar concentration (Fa),The fractional end tidal alveolar concentration (Fa) was adjusted to 1MAC during the maintenance of anesthsia.,"[The pharmacokinetic study of desflurane, sevoflurane, isoflurane and enflurane in general anesthesia]. ",NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/11038831/),,1,171268,DB01189,Desflurane
,23302977,Ce50 BIS,"A separate analysis for the dark- and red-haired subjects estimated a median (95% confidence interval) Ce50 BIS of 2.71 μg/mL (2.28-3.36 μg/mL) and 2.57 μg/mL (1.68-3.60 μg/mL), respectively.",Bispectral index dynamics during propofol hypnosis is similar in red-haired and dark-haired subjects. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23302977/),[μg] / [ml],2.71,177215,DB01189,Desflurane
,23302977,Ce50 BIS,"A separate analysis for the dark- and red-haired subjects estimated a median (95% confidence interval) Ce50 BIS of 2.71 μg/mL (2.28-3.36 μg/mL) and 2.57 μg/mL (1.68-3.60 μg/mL), respectively.",Bispectral index dynamics during propofol hypnosis is similar in red-haired and dark-haired subjects. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/23302977/),[μg] / [ml],2.57,177216,DB01189,Desflurane
,8572357,heart rate,"Without propofol pretreatment, the increase to 8% desflurane transiently increased heart rate (from 63 +/- 3 beats/min to 108 +/- 5 beats/min, mean +/- SEM; P < 0.01), mean arterial pressure (from 73 +/- 1 mmHg to 118 +/- 6 mmHg; P < 0.01), and epinephrine concentration (from 14 +/- 1 pg.ml-1 to 279 +/- 51 pg.ml-1; P < 0.05).",Propofol fails to attenuate the cardiovascular response to rapid increases in desflurane concentration. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8572357/),[beats] / [min],63,177505,DB01189,Desflurane
,8572357,heart rate,"Without propofol pretreatment, the increase to 8% desflurane transiently increased heart rate (from 63 +/- 3 beats/min to 108 +/- 5 beats/min, mean +/- SEM; P < 0.01), mean arterial pressure (from 73 +/- 1 mmHg to 118 +/- 6 mmHg; P < 0.01), and epinephrine concentration (from 14 +/- 1 pg.ml-1 to 279 +/- 51 pg.ml-1; P < 0.05).",Propofol fails to attenuate the cardiovascular response to rapid increases in desflurane concentration. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8572357/),[beats] / [min],108,177506,DB01189,Desflurane
,8572357,peak plasma epinephrine concentration,"The peak plasma epinephrine concentration was attenuated by each propofol pretreatment (158 +/- 35 pg.ml-1, propofol given 2 min before, and 146 + 41 pg.ml-1, propofol given 5 min before; P < 0.05), but neither propofol pretreatment modified the cardiovascular or norepinephrine responses.",Propofol fails to attenuate the cardiovascular response to rapid increases in desflurane concentration. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8572357/),[pg] / [ml],158,177507,DB01189,Desflurane
,8572357,peak plasma epinephrine concentration,"The peak plasma epinephrine concentration was attenuated by each propofol pretreatment (158 +/- 35 pg.ml-1, propofol given 2 min before, and 146 + 41 pg.ml-1, propofol given 5 min before; P < 0.05), but neither propofol pretreatment modified the cardiovascular or norepinephrine responses.",Propofol fails to attenuate the cardiovascular response to rapid increases in desflurane concentration. ,Cmax-Q32,[Article Link](https://pubmed.ncbi.nlm.nih.gov/8572357/),[pg] / [ml],146,177508,DB01189,Desflurane
,30336856,infusion rate,"Mean remifentanil infusion rate [mean (standard deviation)] was significantly higher in the sevoflurane group than in the desflurane group [0.192 (0.064) vs. 0.099 (0.033) μg kg-1 min-1; difference, 0.093 (95% confidence interval, 0.071-0.115); P<0.001].",Desflurane reduces intraoperative remifentanil requirements more than sevoflurane: comparison using surgical pleth index-guided analgesia. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/30336856/),[μg] / [kg·min],0.192,233972,DB01189,Desflurane
,30336856,infusion rate,"Mean remifentanil infusion rate [mean (standard deviation)] was significantly higher in the sevoflurane group than in the desflurane group [0.192 (0.064) vs. 0.099 (0.033) μg kg-1 min-1; difference, 0.093 (95% confidence interval, 0.071-0.115); P<0.001].",Desflurane reduces intraoperative remifentanil requirements more than sevoflurane: comparison using surgical pleth index-guided analgesia. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/30336856/),[μg] / [kg·min],0.099,233973,DB01189,Desflurane
,26752560,clearance,"Mean population parameter estimates for maternal propofol clearance and central volume of distribution were 4.17 L/min and 37.7 L, respectively, in a typical ewe with a median heart rate of 135 beats/min.",Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model. ,CL-Q22,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26752560/),[l] / [min],4.17,250722,DB01189,Desflurane
,26752560,central volume of distribution,"Mean population parameter estimates for maternal propofol clearance and central volume of distribution were 4.17 L/min and 37.7 L, respectively, in a typical ewe with a median heart rate of 135 beats/min.",Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26752560/),l,37.7,250723,DB01189,Desflurane
,26752560,inter-compartment clearance,The estimated population maternal-fetal inter-compartment clearance was 0.0138 L/min and the volume of distribution of propofol in the fetus was 0.144 L.,Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model. ,CL12-Q30,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26752560/),[l] / [min],0.0138,250724,DB01189,Desflurane
,26752560,volume of distribution,The estimated population maternal-fetal inter-compartment clearance was 0.0138 L/min and the volume of distribution of propofol in the fetus was 0.144 L.,Propofol Pharmacokinetics and Estimation of Fetal Propofol Exposure during Mid-Gestational Fetal Surgery: A Maternal-Fetal Sheep Model. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26752560/),l,0.144,250725,DB01189,Desflurane
,26702425,FiO2,"The airway was secured via median tracheostomy with an endotracheal tube, and animals were mechanically ventilated with intermittent positive pressure ventilation (IPPV) with a FiO2 of 0.4, tidal volume (V T)=10 ml/kg and PEEP of 5cmH2O using an open system.",Effects of methacholine infusion on desflurane pharmacokinetics in piglets. ,NIL-Q100,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26702425/),,0.4,252972,DB01189,Desflurane
,26702425,tidal volume (V T),"The airway was secured via median tracheostomy with an endotracheal tube, and animals were mechanically ventilated with intermittent positive pressure ventilation (IPPV) with a FiO2 of 0.4, tidal volume (V T)=10 ml/kg and PEEP of 5cmH2O using an open system.",Effects of methacholine infusion on desflurane pharmacokinetics in piglets. ,V-Q61,[Article Link](https://pubmed.ncbi.nlm.nih.gov/26702425/),[ml] / [kg],10,252973,DB01189,Desflurane
